Log In
Print this Print this

Flublok, Flubok (ASP7374, UMN-0502)

Also known as: ASP-7374

  Manage Alerts
Collapse Summary General Information
Company Protein Sciences Corp.
DescriptionTrivalent seasonal influenza vaccine made with recombinant hemagglutinin antigens purified from cultured insect cells
Molecular Target Not available
Mechanism of ActionVaccine
Therapeutic ModalityPreventive vaccine
Latest Stage of DevelopmentMarketed
Standard IndicationInfluenza virus
Indication DetailsPrevent influenza infection; Prevent influenza infection in children; Prevent seasonal influenza infection; Prevent seasonal influenza infection in adults ages >50; Prevent seasonal influenza infection in elderly adults
Regulatory Designation U.S. - Accelerated Approval (Prevent seasonal influenza infection in adults ages >50)
PartnerAstellas Pharma Inc.;
Biolab Sanus Farmaceutica Ltda.;
Eurofarma Laboratorios S.A.;
Ildong Pharmaceutical Co. Ltd.;
Laboratorios Liomont S.A. de C.V.;
UMN Pharma Inc.

 Product Details
 Archive Items are loading loading
Collapse Summary Deals Information
Total Number of DealsTotal Deal ValueTotal Upfront CashTotal Milestone Payments





 Deals Details
Get a free BioCentury trial today